Article

Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text
Advertising


Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates

  • You can purchase this item in Pay Per ViewPay per View - FAQ : 30,00 € Taxes included to order
    Pages Iconography Videos Other
    4 0 0 0


Joint Bone Spine
Volume 85, n° 6
pages 651-654 (décembre 2018)
Doi : 10.1016/j.jbspin.2018.09.007
accepted : 10 September 2018
Editorials

Switch to a biosimilar: Whatever the cost?
 

Johanna Sigaux a, b, c, , Luca Semerano a, b, c, Marie-Christophe Boissier a, b, c
a Inserm UMR 1125, 74, rue Marcel-Cachin, 93017 Bobigny, France 
b Sorbonne Paris Cité, université Paris 13, 74, rue Marcel-Cachin, 93017 Bobigny, France 
c Assistance publique–Hôpitaux de Paris (AP–HP), groupe hospitalier Avicenne–Jean-Verdier–René-Muret, service de rhumatologie, 125, rue de Stalingrad, 93017 Bobigny, France 

Corresponding author at: Inserm UMR 1125, 74, rue Marcel-Cachin, 93017 Bobigny, France.Inserm UMR 112574, rue Marcel-CachinBobigny93017France

Keywords : Biosimilars, Rheumatoid arthritis, Spondylarthritis, Biologic, Switch, Interchangeability, Cost containment




© 2018  Société française de rhumatologie. All Rights Reserved.
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Close
Article Outline